Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Preferred Shares Issued (2017 - 2023)

Historic Preferred Shares Issued for Fortress Biotech (FBIO) over the last 7 years, with Q1 2023 value amounting to $652000.0.

  • Fortress Biotech's Preferred Shares Issued changed N/A to $652000.0 in Q1 2023 from the same period last year, while for Mar 2024 it was $652000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $17.0 million for FY2021, which is 5656.81% down from last year.
  • Fortress Biotech's Preferred Shares Issued amounted to $652000.0 in Q1 2023.
  • Over the past 5 years, Fortress Biotech's Preferred Shares Issued peaked at $14.4 million during Q1 2020, and registered a low of $263000.0 during Q2 2021.
  • Over the past 4 years, Fortress Biotech's median Preferred Shares Issued value was $8.8 million (recorded in 2019), while the average stood at $7.8 million.
  • In the last 5 years, Fortress Biotech's Preferred Shares Issued soared by 62825.9% in 2019 and then tumbled by 9771.3% in 2021.
  • Over the past 4 years, Fortress Biotech's Preferred Shares Issued (Quarter) stood at $6.0 million in 2019, then soared by 118.62% to $13.2 million in 2020, then plummeted by 68.4% to $4.2 million in 2021, then plummeted by 84.37% to $652000.0 in 2023.
  • Its Preferred Shares Issued was $652000.0 in Q1 2023, compared to $4.2 million in Q3 2021 and $263000.0 in Q2 2021.